Innospec Inc. reported financial results for the second quarter ended June 30, 2026, showing total revenues of $491.4 million, a 12 percent increase from the prior year period. Net income attributable to Innospec was $30.8 million, or $1.25 per diluted share, compared to $23.5 million, or 94 cents per diluted share, in the second quarter of 2025. Adjusted non-GAAP EPS was $1.27 per diluted share. The company paid a semi-annual cash dividend of $0.92 per common share and repurchased shares for $6.4 million. Innospec operates as an international specialty chemicals manufacturer supplying solutions to the personal care, fuel, and oilfield services industries.